Protocol for 18F-FDG quantification in PET-CT whole-body exams

Cellular and Molecular Biology

Volumn 56, Issue 2, 2010, Pages 44-46

  Velasques De Oliveira, S M ^a   Carlos, M T ^a   Carneiro, M P ^b   Da Silva, J W E ^b,c   Kasai, E P ^b,c   Oliveira, A R N ^a,b   Boasquevisque, E M ^c  

^a INSTITUTO DE RADIOPROTEÇÃO E DOSIMETRIA   (Brazil)

^b Multi Imagem PET CT   (Brazil)

^c UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

Author keywords

Computed tomography; External dosimetry; Internal dosimetry; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BREAST; CLINICAL ARTICLE; COLON; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETRY; DRUG HALF LIFE; ESOPHAGUS; FEMALE; GONAD; HUMAN; INTESTINE; IRRADIATION; LIVER; LUNG; LYMPHOMA; MALE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RECTUM; ADOLESCENT; BRAIN; KINETICS; METHODOLOGY; MIDDLE AGED; MULTIMODAL IMAGING; RADIOGRAPHY; RADIOMETRY; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; KINETICS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOMETRY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79959542556     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T894     Document Type: Article

References (19)

1. Bombardieri E., Aktolun C., Baum R.P., Bishof-Delaloye A., Buscombe J., Chatai J.F., Maffioli L., Moncayo R., Mortelmans L., Reske S.N., FDG-PET Procedures guidelines for tumour imaging. EANM, 2003.
2. 18F-FDG PET/CT examinations. J. Nucl. Med. 2005, 46: 608-613.
3. Flux G., Bardies M., Monsieurs M., Savolainen S., Strand S.E., Lassmann M., The impact of PET and SPECT on dosimetry for targeted radionuclide therapy. Z. Med. Phys. 2006, 16: 47-59.
4. 18F-FDG. MIRD Dose estimate report N.19. J. Nuc. Med. 2002 43: 210-214.
5. International Commission on Radiological Protection. Radiation Dose to patients from Radiopharmaceuticals. Addendum to Publication 53. ICRP 80, Oxford Pergamon Press, 1998.
6. International Commission on Radiological Protection. Basic anatomical and physiological data for use in radiological protection: reference values. ICRP 89, Oxford Pergamon Press, 2002.
7. Jones, D.G., Shrimpton, P.,C., Normalized Organ Doses for X-ray Computed Tomography Calculated Using Monte Carlo Techniques. NRPB-SR250, UK National Radiological Protection Boarh, Chilton, 1993.
8. Lewis M.A., Edyvean S., Sassi, S.A., Kiremidjian H., Keat N., Britten A.J. Estimating patient dose on current CT scanners: Results of the ImPACT* CT dose survey (ImPACT, Medical Physics, St. George's Hospital, London). www.impactscan.org (accessed in 12/10/06).
9. Van Dalen J.A., Visser E.P., Vogel W.V., Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET. Med. Phys. 2007, 34: 889-897.
10. Vigil B.R., Gómez-Léon N., Pinilla I., Hernández- Maraver D., Coya J., Martin-Curto L., Madero R., PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT. J. Nucl. Med. 2006, 47:1643-1648.
11. Wahl R.L., Principles of cancer imaging with fluorodeoxyglucose. In: Principles of Positron Emission Tomography, Wahl R.L.and Buchanan, J.W. (eds), Lippincott Willians & Wilkins, Philadelphia, 2002.
12. Correia, M. B. L., Magnata, S. S. L. P., Silva, I. M. S., Catanho, M. T. J. A. and Lima, F. F. Biokinetics and dosimetric studies about 99MTC(V)-DMSA distribution. Cell. Mol. Biol., 2010, 56 (2): 1-5.
13. Couto, R. M., De Barboza, M. F., De Souza, A. A., Muramoto, E., Mengatti, J. and De Araújo, E. B. In vivo comparative study of hydroxyapatite labeled with different radioisotopes: evaluation of the scintigraphic images. Cell. Mol. Biol., 2010, 56 (2): 6-11.
14. De Araújo, E. B., Pujatti, P. B. and Mengatti, J. Radiolabeling of substance p with lutetium-177 and biodistribution study in rat pancreatic tumor xenografted nude mice. Cell. Mol. Biol., 2010, 56 (2): 12-17.
15. Pujatti, P. B., Santos, J. S., Massicano, A. V. F., Mengatti, J. and De Araújo, E. B. Development of a new bombesin analog radiolabeled with lutetium-177: in vivo evaluation of the biological properties in balb-c mice. Cell. Mol. Biol., 2010, 56 (2): 18-24.
16. Yano, V. F. and Lima, F. F. Radiation exposure from diagnostic nuclear medicine in alagoas (Brazil) in 2002-2005. Cell. Mol. Biol., 2010, 56 (2): 25-30.
17. Melo, I.B., Ueda, L.T., Araujo, E.B., Muramoto, E., Barboz, M.F., Mengatti, J., Buchpiguel, C.A. and Silva, C.P.G. Tecnetium-99m as alternative to produce somatostatin-labeled derivatives: comparative biodistribution evaluation with 111in-dtpa-octreotide. Cell. Mol. Biol., 2010, 56 (2): 31-36.
18. Silva, I C. O. A., Lucena, E. A., Souza, W. O., Dantas, A. L. A. and Dantas, B. M. Estimation of internal exposure to 99mo in nuclear medicine patients. Cell. Mol. Biol., 2010, 56 (2): 37-40.
19. Velasques De Oliveira, S. M., Julião, L. M. Q. C., Sousa, W. O., Mesquita, S. A. and Santos, M. S. Methodology for radionuclides quantification through "in vitro" bioassay. Cell. Mol. Biol., 2010, 56 (2): 31-43.